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Kathryn B. Garber1,*Privacy Protection for GWAS Participants
Changes are afoot to the National Institutes of Health
(NIH) policy on the availability of data from genome-
wide association studies (GWAS). Beginning this year, the
NIH had instituted a policy that summary data from all
NIH-funded GWAS be submitted to an open-access reposi-
tory to facilitate data sharing. As of the end of August, this
policy was put on hold, and all previously submitted aggre-
gate results from GWAS studies were removed from the
NIH’s open-access databases. This reversal is due to the
publication of a paper by Homer et al. reporting a method
of determining whether an individual’s genomic data are
part of a larger set of SNP microarray data. The fear is
that someone could glean personal health information,
such as a person’s disease status, with this technique if
one could place a particular person in the ‘‘case’’ or ‘‘con-
trol’’ group of samples in a GWAS. Lest any research partic-
ipants be overly concerned, let it be noted that one would
need to get an individual’s high-density genotype data
from another source in order to use this method; such
a thing is unlikely to happen outside the research setting
at this point. Nonetheless, for the time being, aggregate
GWAS data will only be available in controlled-access data-
bases so that the privacy of research participants is en-
sured. Undoubtedly, the NIH’s policy toward GWAS data
will evolve as the implications of this technique are
examined.
Homer et al. (2008). PLoS Genetics 4, e1000167. 10.1371/
journal.pgen.1000167.
Preventing Statin-Induced Myopathy
Statins are widely prescribed drugs that reduce low-density
lipoprotein (LDL) cholesterol levels. Although statins
lower the risk of a cardiovascular event, they are some-
times, albeit rarely, associated with myopathy. During
the Study of the Effectiveness of Additional Reductions
in Cholesterol and Homocysteine (SEARCH) trial, which
aims to identify the most efﬁcacious dose of simvastatin,
more than 100 of the 12,000 participants experienced my-
opathy brought on by the drug. The vast majority of these
cases occurred in people taking the higher of the two drug
dosages in the trial. The SEARCH collaborative group used
a genome-wide association study to identify genetic factorsassociated with this adverse event and found one SNP that
explainedmore than 60% of the cases ofmyopathy in their
study. This SNP resides in SLCO1B1, which encodes the
transporter that mediates uptake of the statins into the
liver. In fact, it appears that the myopathy risk allele in
SLCO1B1, which is quite common, may be associated
with higher statin blood concentrations that, in turn,
cause myopathy. Although further research is needed to
cement the role of SLC01B1 in statin-induced myopathy,
reduced cardiovascular risks may need to be balanced
with the risk of myopathy when the statin dosage for a par-
ticular patient is being determined. SLCO1B1 genotype
may eventually ensure that we get the maximum beneﬁt
from these drugs by allowing us to restrict the prescription
of high statin doses to people at the lowest risk of an
adverse event.
The SEARCH Collaborative Group (2008). New Engl. J. Med.
359, 789–799. 10.1056/NEJMoa0801936.
A Molecular Link between Obesity and Fertility
We tend to think of obesity as a simple energy problem
whereby too much fuel is taken in and not enough is
expended. But on a molecular level, obesity can also be
thought of as a signaling defect that has additional conse-
quences, including reduced fertility. The adipocyte-derived
hormone leptin is a key signal that maintains the energy
balance. If you wipe out leptin signaling, you get obese,
infertile mice. Leptin regulates the STAT3 pathway, but
clearly, there are other leptin-mediated pathways because
mice that lack leptin-induced STAT3 signaling, although
obese, are also fertile. Altarejos et al. report that the
Creb1-Crtc1 pathway is central to both the energy balance
and fertility-associated effects of leptin signaling. Crtc1
acts downstream of leptin and enhances Creb1’s induction
of genes involved in appetite and in fertility. Mice that lack
Crtc1 are obese, hyperphagic and totally infertile. Many
obese humans are leptin resistant; they don’t appropriately
reduce their appetite and increase their energy expenditure
in response to increased energy stores. Altarejos et al.
propose a hunt for genetic variation in CRTC1 that may
contribute to the propensity for obesity in humans. This
pathway also could form the basis for attempts at pharma-
cologic intervention to moderate obesity and its associated
effects on fertility.1Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA
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Altarejos et al. (2008). Nature Medicine. Published online
August 31, 2008. doi:10.1038/nm.1866.
Methylcytosine Double FlipHow Do I Love Thee?
I’d like to think my husband married me for my brain or
my keen sense of wit, but did he instead stick around be-
cause he has a particular allele of the gene for the vasopres-
sin receptor 1a (AVPR1A)? Pair bonding in voles is inﬂu-
enced by arginine vasopressin (AVP), and variation in the
50 region of the gene for its receptor, V1aR, is known to af-
fect social behavior and partner preference in voles. This
gaveWallum et al. the idea to determine whether variation
in human AVPR1A might inﬂuence social behavior. Data
for their research comes from the Twin andOffspring Study
in Sweden, which collected detailed measurements of mar-
ital relationships in twin pairs and their spouses. They
found evidence that, in males only, variation in a repeat
polymorphism in the 50 ﬂanking region of AVPR1A is asso-
ciated withmeasurements of partner bonding and the like-
lihood of marital crisis. Although all couples in this study
were required to be in long-term relationships, men homo-
zygous for the 334 allele at this polymorphismwere almost
half as likely to be married as those lacking this allele. It
doesn’t seem very romantic to me to boil down love and
bonding to a single gene, but Wallum et al. argue that AV-
PR1A alone may inﬂuence these social behaviors. In an-
swer to the question, ‘‘How do I love thee?,’’ perhaps we
should be counting AVPR1A as one of the ways.
Wallum et al. (2008) Proc. Natl. Acad. Sci. 105, 14153–
14156. 10.1073/pnas.0803081105.434 The American Journal of Human Genetics 83, 433–434, OctobeWe geneticists know that Watson-Crick base-pairing is the
key to faithful DNA replication, but it is less clear how the
epigeneticmarks onDNAaremaintainedwithhighﬁdelity.
The maintenance DNA methyltransferase DNMT1 is the
enzyme that does the job, but it is its binding partner
UHRF1 that givesDNMT1ahigh speciﬁcity forhemimethy-
lated DNA. Three recent papers in Nature illustrate how
UHRF1 gets its speciﬁcity. Each reports a high-resolution
crystal structure for UHRF1 bound to DNA. It turns out
that this protein is the ﬁrst nonenzyme that uses a base-ﬂip-
ping mechanism in its interaction with DNA. The 5-meth-
ylcytosine in hemimethylated DNA ﬂips out of the double
helix and into a binding pocket of the SRA domain of
UHRF1. The tight interaction with the ﬂipped-out base ex-
plains the speciﬁcity of UHRF1 for hemimethylated DNA.
This pocket binds unmethylated DNA nonspeciﬁcally,
whereas full methylation of DNA perturbs the interaction.
DNMT1 probably also ﬂips a base out when it binds DNA,
but steric hindrance prevents UHRF1 and DNMT1 from
doing this trick at the same time. Arita et al. propose that
UHRF1 ﬁrst uses a base ﬂip to identify hemimethylated
DNA. It then recruits DNMT1, which subsequently ﬂips
a cytosine to facilitate the transfer of the epigenetic mark
to the daughter DNA strand.
Avvakumov et al. (2008). Nature. Published online Septem-
ber 3, 2008. 10.1038/nature07273.
Arita et al. (2008). Nature. Published online September 3,
2008. 10.1038/nature07249.
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